As we look ahead to 2026, the operational demands on 340B programs are increasing across every dimension. Between the implementation of the 340B ...

Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.

Hospital groups raise issues with 340B rebate pilot program citing cash flow, administrative costs, and unclear rebate denials risks.

Too many hospitals take advantage of 340B, intended to make medications affordable for low-income patients. A New York proposal would make things worse.

Michigan hospitals are systematically exploiting a program for low-income patients, according to a new report.

Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...

All North Dakotans surely know the adage, “If it ain’t broke, don’t fix it.” Well, some North Dakota state lawmakers are test-driving a new concept: “If it is broke, pretend it’s not.” And the ...

The 340B Drug Pricing Program was originally constructed so safety-net health care facilities could stretch scarce resources in caring for low-income patients. However, the program has experienced ...

The 340B Drug Pricing Program was meant to help low-income patients, writes Rick Dowlearn, but it’s being used by hospitals ...

An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug ...